BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND MYD88, Q99836, MYD88D, 4615 AND Diagnosis
27 results:

  • 1. Multiple Genomic Alterations, Including a Novel
    Sahin Y; Wang YL; Pei J; Mansoor N; Styler M; Testa JR; Nejati R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203475
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bing-Neel syndrome: a rare neurological complication of Waldenström macroglobulinaemia.
    Alzghoul H; Haider A; Mukhtar F; Khuddus N
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38182164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Challenging diagnosis of IgM multiple myeloma.
    Mahmood F; Ahmed B; Thalody V; Mehdi S
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38176750
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria.
    Treon SP; Tedeschi A; San-Miguel J; Garcia-Sanz R; Anderson KC; Kimby E; Minnema MC; Benevolo G; Qiu L; Yi S; Terpos E; Tam CS; Castillo JJ; Morel P; Dimopoulos M; Owen RG
    Semin Hematol; 2023 Mar; 60(2):97-106. PubMed ID: 37173155
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
    Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
    Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation.
    Zhang ML; Sabatino ME; Castillo CF; Mattia AR; Chebib I
    Diagn Cytopathol; 2023 May; 51(5):E164-E169. PubMed ID: 36762822
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
    Fend F; Dogan A; Cook JR
    Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Waldenström disease: News and perspectives in 2022].
    Bouclet F; Krzisch D; Leblond V; Tomowiak C; Laribi K; Ysebaert L; Tournilhac O; Dartigeas C; Leprêtre S; Jondreville L;
    Bull Cancer; 2023 Jan; 110(1):88-100. PubMed ID: 36229266
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
    Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
    Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. VITREORETINAL INVOLVEMENT BY INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER OF THE GASTROINTESTINAL TRACT DIAGNOSED BY FLUORESCENCE IN SITU HYBRIDIZATION.
    Salman AR; Ferenchak K; Olsen TW; Smith WM; Ketterling RP; McPhail ED; Salomao DR; Dalvin LA
    Retin Cases Brief Rep; 2023 Sep; 17(5):572-576. PubMed ID: 37490925
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
    Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ
    Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow - Results from a single centre pilot study.
    Gautam A; Sreedharanunni S; Sachdeva MUS; Rana S; Kashyap D; Bose P; Bal A; Prakash G; Malhotra P; Das R; Varma N
    Int J Lab Hematol; 2021 Oct; 43(5):1123-1131. PubMed ID: 33455071
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Management of Waldenström macroglobulinemia in 2020.
    Castillo JJ; Treon SP
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):372-379. PubMed ID: 33275726
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. On point in primary CNS lymphoma.
    Tsang M; Cleveland J; Rubenstein JL
    Hematol Oncol; 2020 Dec; 38(5):640-647. PubMed ID: 32510610
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. An unusual case of cutaneous Waldenström macroglobulinemia with the myd88 L265P mutation.
    Minzenmayer AN; Miranda RN; Powell PR; Parekh PK
    J Cutan Pathol; 2020 Sep; 47(9):850-853. PubMed ID: 32335928
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group.
    Maqbool MG; Tam CS; Morison IM; Simpson D; Mollee P; Schneider H; Chan H; Juneja S; Harvey Y; Nath L; Hissaria P; Prince HM; Wordsworth H; Opat S; Talaulikar D
    Pathology; 2020 Feb; 52(2):167-178. PubMed ID: 31902622
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis.
    Wang W; Lin P
    Pathology; 2020 Jan; 52(1):6-14. PubMed ID: 31767130
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. What is new in the treatment of Waldenstrom macroglobulinemia?
    Castillo JJ; Treon SP
    Leukemia; 2019 Nov; 33(11):2555-2562. PubMed ID: 31591468
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic Entity.
    Bonilla-Valentín FJ; Cerra J; Cáceres-Perkins W; Alsina M
    Cancer Control; 2018; 25(1):1073274817744448. PubMed ID: 29318955
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. myd88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.
    Treon SP; Gustine J; Xu L; Manning RJ; Tsakmaklis N; Demos M; Meid K; Guerrera ML; Munshi M; Chan G; Chen J; Kofides A; Patterson CJ; Yang G; Liu X; Severns P; Dubeau T; Hunter ZR; Castillo JJ
    Br J Haematol; 2018 Feb; 180(3):374-380. PubMed ID: 29181840
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.